Brownstein Client Conversations: OvaCure
Kristin Parello-Plesner, Strategic Director for OvaCure, joins Brownstein Policy Advisor Araceli Gutierrez for a discussion on how OvaCure is challenging the current paradigms in cancer research. As OvaCure signed its first US-based ovarian cancer research project at the University of Pennsylvania, Brownstein has worked with OvaCure to connect with and establish a strong network of key US stakeholders. Kristin and Araceli discuss how U.S.-Danish relations can attract more innovation to the United States and highlight the importance of social philanthropy and its critical role in funding for ovarian cancer research.
Recent Insights
Read MoreThe Legal Implications of President Trump’s Tariff Policy
Client Alert | January 12, 2026California’s New “Workplace Know Your Rights” Act: What Employers Need to Know
Client Alert | January 10, 2026President Trump Announces Major Housing Policy Shifts, with Broader Executive Order Expected
Client Alert | January 09, 2026California State Budget 2026-27
Client Alert | January 09, 2026Tax Regulatory Update
Client Alert | January 08, 2026FCC Extends Compliance Deadline for “Revoke All” Rule
You have chosen to send an email to Brownstein Hyatt Farber Schreck or one of its lawyers. The sending and receipt of this email and the information in it does not in itself create and attorney-client relationship between us.
If you are not already a client, you should not provide us with information that you wish to have treated as privileged or confidential without first speaking to one of our lawyers.
If you provide information before we confirm that you are a client and that we are willing and able to represent you, we may not be required to treat that information as privileged, confidential, or protected information, and we may be able to represent a party adverse to you and even to use the information you submit to us against you.
I have read this and want to send an email.